Fortis Capital Advisors’s ResMed RMD Stock Holding History

Fortis Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-75	Closed	-$16.4K	–	499
2023 Q1	$16.4K	Buy	+75	New	+$16.3K	0.01%	420

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fortis Capital Advisors's RMD Position: Q2 2023 in Review

Fortis Capital Advisors sold out of ResMed (RMD) in Q2 2023, closing a stake of 75 shares — an estimated $16.4K sold.

Fortis Capital Advisors first reported a position in RMD in Q1 2023 and held it in 1 quarter. The position peaked at $16.4K in Q1 2023. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

Fortis Capital Advisors reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
Fortis Capital Advisors sold 75 ResMed shares in Q2 2023, an estimated $16.4K.
Fortis Capital Advisors first reported a position in ResMed in Q1 2023 and held it in 1 quarter.
Fortis Capital Advisors's ResMed position peaked at $16.4K in Q1 2023.
731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Fortis Capital Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.